Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

VTRS vs PARA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VTRS Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 9–1 Matrix Metrics)

VTRS Overall Winner 6-Pillar Tally: VTRS 6 – 0 PARA Matrix Metrics: VTRS 9 – 1 PARA

As of Nov 20, 2026, Viatris Inc. (VTRS) is the stronger overall head-to-head candidate over PARA (PARA) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VTRS carries a Unified Composite Score of 52.2/100 (HOLD) at $19.63 (7.1x Forward P/E, 11.5% operating margin), whereas PARA carries 53.3/100 (HOLD) at $0.03 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While PARA currently prints a higher short-term Unified Composite Score (53.3/100 HOLD vs. VTRS 52.2/100 HOLD), VTRS captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (11.5% vs. N/A operating margin) and revenue trajectory (-0.3% vs. N/A YoY).
  • Technical & Structure Timing Caution: VTRS trades in a Markup technical trend (BREAKOUT options phase, RSI 52.3); meanwhile PARA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VTRS vs PARA
VTRS NASDAQ Head-to-Head Winner
Viatris Inc. Common Stock
Pharmaceutical Preparations
$19.63
-1.26% 1D
Market Cap $22.8B
TTM Revenue $14.7B
Forward P/E 7.1x
Beta / 30D Vol 0.55β · 31% Vol
Unified Composite Score
52.2 / 100 HOLD
Tech 37.0 Fund 53.0 Flow 68.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.4% over 20 days), RSI 52
RSI-14: 52.3 · SMA20: $19.73 · SMA50: $18.47
PARA US Equity
PARA
Institutional Equity
$0.03
-23.29% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 12.61β · 3359% Vol
Unified Composite Score
53.3 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.8%), weak momentum, RSI 42
RSI-14: 42.0 · SMA20: $1.07 · SMA50: $0.84

6-Pillar Scorecard Institutional Category Breakdown (VTRS 6 – 0 PARA)

Columns: Metric · VTRS · PARA
1. Valuation Multiples VTRS
Forward P/E 7.1x N/M
Trailing P/E 7.4x N/M
PEG Ratio 3.69x N/M
EV / Revenue 2.3x N/M
2. Growth & Scale VTRS
Revenue Growth (YoY) -0.3% N/A
Earnings Growth (YoY) -70.6% N/A
TTM Revenue (USD) $14.7B N/A
Market Cap $22.8B N/A
3. Profitability & Quality VTRS
Gross Margin 41.1% N/A
Operating Margin 11.5% N/A
Net Profit Margin -4.1% N/A
Return on Equity (ROE) -4.2% N/A
4. Balance Sheet & Cash Flow VTRS
Cash Generation (TTM) $1.98B N/A
Cash Flow Margin 13.4% N/A
Net Cash / Leverage $11.8B Net Debt (0.99x D/E) N/A ROE
Dividend Yield 2.37% None (0.00%)
5. Options & Positioning VTRS
Options Structure Phase BREAKOUT UNCLASSIFIED
Current IV / %ile 31.9% (42nd %ile) N/A (N/A)
Put/Call OI Skew 0.24x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat VTRS
OpEx & R&D Intensity 29.6% of Rev ($4.36B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Drug Manufacturers - Specialty & Generic Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VTRS (9) vs PARA (1)
Institutional Metric VTRS PARA Criterion Row Edge
Market Capitalization
Scale
$22.8B N/A Larger Scale VTRS
Trailing P/E Ratio
Valuation
7.4x N/M Lower Multiple VTRS
Forward P/E Ratio
Valuation
7.1x N/M Lower Multiple VTRS
Revenue Growth (YoY)
Growth
-0.3% N/A Higher Growth VTRS
Operating Margin (TTM)
Profitability
11.5% N/A Higher Margin VTRS
Net Profit Margin
Profitability
-4.1% N/A Higher Margin VTRS
Return on Equity (ROE)
Capital Efficiency
-4.2% N/A Higher ROE VTRS
52-Week Range Position
Momentum
86% ($10–$21) 0% ($0–$9) Stronger Trend VTRS
Beta / 30D Volatility
Risk Regime
0.55β · 31% Vol 12.61β · 3359% Vol Lower Realized Risk VTRS
Unified Institutional Score
Composite Signal
52.2 / 100 (HOLD) 53.3 / 100 (HOLD) Higher Composite PARA
Trailing 12M Revenue (USD)
Operating Scale
$14.7B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
41.1% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.69x PEG · 2.3x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.98B ($11.8B Net Debt (0.99x D/E)) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VTRS +100.27 pp
VTRS: +6.22% · PARA: -94.05%
3M Horizon VTRS +116.35 pp
VTRS: +18.68% · PARA: -97.67%
6M Horizon VTRS +117.89 pp
VTRS: +19.48% · PARA: -98.41%
1Y Horizon VTRS +117.89 pp
VTRS: +19.48% · PARA: -98.41%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VTRS vs PARA. Trailing 12-month operating profitability (VTRS 11.5% vs PARA N/A) and valuation multiples (VTRS 7.1x vs PARA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

VTRS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.7B
Gross Margin41.1%
Op. Margin11.5%
ROE / Fwd P/E-4.2% · 7.1x
PARA ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VTRS BREAKOUT
137d in phase · OBV DISTRIBUTION
Current IV 31.9%
IV Percentile 42nd %ile
Put/Call OI Skew 0.24x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact VTRS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PARA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PARA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $20.74 · IV 31.3%

VTRS Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($2,074)

Compare $2,074 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 31.3% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $21 / $22 Bull Call Spread

Buy 2x $21C · Sell 2x $22C · 32d

Net Entry $78 Debit
T+5d @ +5% Move +$42 (+54%)
Max Risk / Buffer $78 Capped
5d Edge & Liquidity 0.9x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Jan 15 '27 $19 / $17 Bull Put Spread

Sell 2x $19P · Buy 2x $17P · 60d

Net Entry $80 Credit
Max Credit / Yield +$80 (+25.0% RoM)
Max Risk / Buffer -10.3% Cushion ($320 Mgn)
5d Edge & Liquidity 76% PoP · Liq B
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq C

Dec 18 $21 / $20 Bear Put Spread

Buy 2x $21P · Sell 2x $20P · 32d

Net Entry $70 Debit
T+5d @ -5% Drop +$49 (+70%)
Max Risk / Buffer $70 Capped
5d Edge & Liquidity 1.1x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VTRS Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $22.8B market capitalization and 11.5% operating margin.
OpEx & R&D Reinvestment 29.6% of Rev ($4.36B)
90D Engineering Disclosures 0 Published
PARA Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ VTRS vs PARA Key Questions & Quantitative Answers

As of Nov 20, 2026, Viatris Inc. (VTRS) is the stronger overall head-to-head candidate over PARA (PARA) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VTRS carries a Unified Composite Score of 52.2/100 (HOLD) at $19.63 (7.1x Forward P/E, 11.5% operating margin), whereas PARA carries 53.3/100 (HOLD) at $0.03 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While PARA currently prints a higher short-term Unified Composite Score (53.3/100 HOLD vs. VTRS 52.2/100 HOLD), VTRS captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (11.5% vs. N/A operating margin) and revenue trajectory (-0.3% vs. N/A YoY). Technical & Structure Timing Caution: VTRS trades in a Markup technical trend (BREAKOUT options phase, RSI 52.3); meanwhile PARA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VTRS leads the Growth & Scale pillar: VTRS posts -0.3% YoY revenue growth and -70.6% YoY earnings growth on $14.7B TTM revenue (41.1% gross margin, 11.5% operating margin), compared with PARA at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, VTRS generates $14.7B in USD-normalized revenue versus N/A for PARA. In operating R&D and SG&A reinvestment, VTRS deploys 29.6% of Rev ($4.36B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PARA.

VTRS screens cheaper on headline valuation multiples. VTRS trades at 7.1x Forward P/E, 7.4x Trailing P/E, 3.69x PEG, and 2.3x EV/Revenue (13.4% FCF margin), whereas PARA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VTRS (-4.2% ROE) versus PARA (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, VTRS carries 31.9% implied volatility (42nd %ile, Balanced (25th–60th %ile)), a 0.24x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKOUT options structure phase (0.55β · 31% Vol realized risk). By comparison, PARA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (12.61β · 3359% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.